These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. The utilization of antibiotics in the management of acute pancreatitis--experience from one transitional country university hospital. Marusić S; Sićaja M; Kujundzić M; Banić M; Jaksić O; Vrazić H Coll Antropol; 2008 Dec; 32(4):1189-94. PubMed ID: 19149227 [TBL] [Abstract][Full Text] [Related]
85. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Han XC; Zhang YC; Wang Y; Jia MK Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):135-8. PubMed ID: 14607666 [TBL] [Abstract][Full Text] [Related]
86. [Clinico-immunological variants of the course of chronic pancreatitis]. Trukhan DI Ter Arkh; 2001; 73(2):20-4. PubMed ID: 11338848 [TBL] [Abstract][Full Text] [Related]
87. Specific and non-specific humoral responses in human trypanosomiasis. A case report of documented pre-infection immune status. Njelesani EK; Kakoma I; Atenyi JR; Ulrich AM East Afr Med J; 1984 Mar; 61(3):234-41. PubMed ID: 6548180 [No Abstract] [Full Text] [Related]
88. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Powell JJ; Fearon KC; Siriwardena AK; Ross JA Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456 [TBL] [Abstract][Full Text] [Related]
89. [The diagnosis and treatment of acute pancreatitis]. Syrbu IF; Kapshitar' AV; Mogil'nyĭ VA Khirurgiia (Mosk); 1993 Jan; (1):47-51. PubMed ID: 8336453 [TBL] [Abstract][Full Text] [Related]
90. [Method for absorption of heterophile hemagglutinins in the SvartzSchlossmann reaction]. Spencker FB; Handrick W; Gerisch R Z Gesamte Hyg; 1971 Oct; 17(10):771-3. PubMed ID: 5172444 [No Abstract] [Full Text] [Related]
91. [The relationship of the treatment results in acute pancreatitis to the correctness of the diagnosis of the stages of the disease]. Briskin BS; Iatsenko AA; Nazarov VN Vestn Khir Im I I Grek; 1996; 155(5):21-4. PubMed ID: 9123749 [TBL] [Abstract][Full Text] [Related]
92. [Features of the immune status in acute pancreatitis]. Tarasenko VS; Smoliagin AI; Kubyshkin VA Khirurgiia (Mosk); 2000; (8):51-5. PubMed ID: 10997008 [No Abstract] [Full Text] [Related]
93. [Quantitative changes in immunoglobulins in patients with suppurative affections of the lungs]. Prozorovskaia KN; Nedvetskaia LM; Smoliar VA; Esinenko NV Grudn Khir; 1972; 14(1):48-53. PubMed ID: 5011215 [No Abstract] [Full Text] [Related]
94. [Status of body reactivity and the activity of the antioxidant system of acute cholecystitis patients]. Liul'ka AN; Gorlachev MI Vrach Delo; 1984 Dec; (12):78-81. PubMed ID: 6523832 [No Abstract] [Full Text] [Related]
95. [Immunobiological reactivity in pancreatitis]. Kobyliatskiĭ IT Klin Med (Mosk); 1979 May; 57(5):87-90. PubMed ID: 480874 [No Abstract] [Full Text] [Related]
96. [Immune disorders in acute pancreatitis and principles of immunocorrecting therapy]. Krivoruchko IA Klin Khir; 1997; (1):11-4. PubMed ID: 9254254 [TBL] [Abstract][Full Text] [Related]
97. [Antibody formation in patients with erysipeloid]. Denisov GI; Karal'nik BV; Chiakovskiĭ VT; Gerasimenko IV Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):40-4. PubMed ID: 6895571 [No Abstract] [Full Text] [Related]
98. [The current treatment of acute pancreatitis]. Poilleux F; Stroz G Actual Hepatogastroenterol (Paris); 1964; ():289-97. PubMed ID: 5849782 [No Abstract] [Full Text] [Related]